rs748758482
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4BP7
This summary comes from the ClinGen Evidence Repository: NM_001754.5(RUNX1):c.96C>T (p.His32=) is a synonymous variant which has a SpliceAI score ≤ 0.20 (0.09) and evolutionary conservation algorithms predict the site as not being conserved (PhyloP score ≤ 2.0 [-0.498]) (BP4, BP7). In summary, this variant meets criteria to be classified as likely benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BP4, BP7. LINK:https://erepo.genome.network/evrepo/ui/classification/CA10014630/MONDO:0011071/008
Frequency
Consequence
NM_001754.5 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 249524Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 134922
GnomAD4 exome AF: 0.00000357 AC: 5AN: 1399848Hom.: 0 Cov.: 25 AF XY: 0.00000429 AC XY: 3AN XY: 699926
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome Benign:1
NM_001754.5(RUNX1):c.96C>T (p.His32=) is a synonymous variant which has a SpliceAI score ≤ 0.20 (0.09) and evolutionary conservation algorithms predict the site as not being conserved (PhyloP score ≤ 2.0 [-0.498]) (BP4, BP7). In summary, this variant meets criteria to be classified as likely benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BP4, BP7. -
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at